CardioComm Solutions

CardioComm Solutions FCF Conversion

The FCF Conversion Rate (FCF/EBITDA) of CardioComm Solutions (EKG.V) as of Oct 9, 2026 is 59.46 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was 57.66 % — a change of 3.12% (higher).

FCF Conversion

59.46 %

YoY

3.12%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of CardioComm Solutions is 2024 59.46 % . FCF Conversion Rate (FCF/EBITDA) of CardioComm Solutions was 2023 57.66 % . It decreases by 3.12% higher compared to the previous year.

The CardioComm Solutions FCF Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Conversion
Date
FCF Conversion
Jan 1, 2017
-739.65 CAD
Jan 1, 2018
36.16 CAD
Jan 1, 2019
6.63 CAD
Jan 1, 2020
-36.79 CAD
Jan 1, 2021
-41,133.33 CAD
Jan 1, 2022
-1,772.00 CAD
Jan 1, 2023
57.66 CAD
Jan 1, 2024
59.46 CAD
The CardioComm Solutions FCF Conversion history
YEARFCF ConversionYoY
59.46 %+3.12%
57.66 %-103.25%
-1,772.00 %-95.69%
-41,133.33 %+111,698.29%
-36.79 %-655.07%
6.63 %-81.67%
36.16 %-104.89%
-739.65 %-212.04%
660.17 %+1,211.60%
50.33 %-1.06%
50.87 %—
Access this data via the Eulerpool API
Get Free API Key

CardioComm Solutions Stock analysis

What does CardioComm Solutions do? CardioComm Solutions Inc is a Canadian company specialized in the development and marketing of monitoring and management solutions for EKG data. The company offers innovative products and services aimed at improving the efficiency and quality of EKG monitoring. History: CardioComm Solutions Inc was founded in 1994 by Etienne Grima in Toronto. Since its establishment, the company has developed a variety of products and services that provide easy and effective access to EKG data. Over the years, CardioComm Solutions Inc has received several awards, including the Innovations Award from Canadian Healthcare Technology in 2008. Business model: CardioComm Solutions Inc's business model includes the development and marketing of EKG monitoring solutions for various markets. The company offers products and services for hospitals, clinics, medical facilities, and other healthcare providers. It also provides solutions for consumer and fitness markets. The company has built an extensive network of partners in North America, Europe, and Asia to provide its customers worldwide with quick and easy access to its products and services. Divisions: CardioComm Solutions Inc offers various divisions. An important focus is on the development of EKG monitoring systems for hospitals and medical facilities. These solutions are aimed at improving workflow and patient monitoring efficiency. Another important area is telemedicine. The company offers solutions that allow patients to monitor their EKG data from home and share it with their doctors. This enables more effective monitoring of patients with heart problems, especially in regions with limited access to medical care. In addition, the company also offers solutions for consumer and fitness markets. One of the company's best-known brands is KardiaMobile. KardiaMobile is a portable EKG device held in the hand and connected to a smartphone app that allows for quick and accurate heart rhythm monitoring. The company has also developed a similar device called KardiaBand, which is worn in the form of a wristband. Products: CardioComm Solutions Inc's products include a variety of EKG monitoring solutions tailored to the needs of different markets. One of the well-known solutions is the Global EKG Management System (GEMS). GEMS is a web-based solution that enables reception, display, and access to EKG data from various locations. The company also offers mobile solutions, including KardiaMobile and KardiaBand, as well as solutions for clinical studies and research projects. Additionally, the company provides training and support for its products and services. Conclusion: CardioComm Solutions Inc is an innovative company that offers a wide range of EKG monitoring and management solutions for various markets. The company has built a reputation for quality and reliability and has a strong presence in the global market. With its advanced technology and dedicated professionals, CardioComm Solutions Inc is well-positioned to achieve further growth and success in the coming years. CardioComm Solutions is one of the most popular companies on Eulerpool.

Frequently Asked Questions about CardioComm Solutions stock

FCF Conversion Rate (FCF/EBITDA) of CardioComm Solutions is 59.46 % in 2024.

FCF Conversion Rate (FCF/EBITDA) of CardioComm Solutions changed from 57.66 % to 59.46 %, representing a 3.12% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) CardioComm Solutions since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s CardioComm Solutions with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API
Get Free API Key

Cash Flow — CardioComm Solutions

Operating Cash FlowCapital ExpendituresFree Cash FlowFCF per ShareDividends PaidShare BuybacksInvesting Cash FlowFinancing Cash FlowCapEx / RevenueCash Flow per ShareStock-Based CompensationChange in Working CapitalAcquisitions (Net)Net Change in CashCapEx/OCFFCF/Net IncomeFCF ConversionCash ConversionTotal Shareholder PayoutCapEx/D&A

All Key Metrics — CardioComm Solutions